In EDS ansehen

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x)

Gespeichert in:
Bibliographische Detailangaben
Titel: Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x)
Autoren: Dam T, Boxer AL, Golbe LI, Hoglinger GU, Morris HR, Litvan I, Lang AE, Corvol J-C, Aiba I, Grundman M, Yang L, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O'Gorman J, Haeberlein SB, Antonini A, Apetauerova D, Azulay J-P, Martinez EB, Bang J, Barone P, Barrett M, Bega D, Berg D, Corrales KB, Bordelon Y, Brandt M, Brueggemann N, Castelnovo G, Ceravolo R, Chuang R, Chung SJ, Church A, Cudia P, Dale M, Defebvre L, Drapier S, Driver-Dunckley ED, Ebersbach G, Eggert KM, Ellenbogen A, Eusebio A, Evans AH, Fedorova N, Finger E, Foubert-Samier A, Ghosh B, Golbe L, Perez FG, Grossman M, Hall D, Hamada K, Hasegawa K, Hoeglinger G, Honig L, Houghton D, Huang X, Isaacson S, Koh SB, Bojarski JK, Leigh PN, Lozano JJL, Moreno JLL-S, Ludolph AC, Piudo MRL, Torres IM, McFarland N, Meissner W, Mestre T, Rivera PM, Molho E, Mollenhauer B, Murata M, Obi T, Magne FO, O'Suilleabhain P, Pahwa R, Pantelyat A, Pavese N, Pokhabov D, Prudlo J, Rodriguez-Porcel F, Rowe J, Savitt J, Schnitzler A, Schulz JB, Seppi K, Shah B, Shill H, Shprecher D, Stamelou M, Steiger M, Takahashi Y, Takigawa H, Tartaglia C, Toenges L, Truong D, Tse W, Tuite P, Volc D, Wills A-MA, Woitalla D, Xie T, Yuasa T, Zauber SE, Zesiewicz T
Quelle: Nature Medicine, 2022
Verlagsinformationen: Nature Research
Publikationsjahr: 2022
Bestand: Newcastle University Library ePrints Service
Beschreibung: © The Author(s), under exclusive licence to Springer Nature America, Inc. 2022.In the version of this article initially published, members of the PASSPORT Study Group were listed in Supplementary information but not included in the main article. The contributors are listed below for inclusion in authorship.
Publikationsart: text
Sprache: unknown
Relation: https://eprints.ncl.ac.uk/287529
Verfügbarkeit: https://eprints.ncl.ac.uk/287529
Dokumentencode: edsbas.B9FC85D0
Datenbank: BASE
Beschreibung
Abstract:© The Author(s), under exclusive licence to Springer Nature America, Inc. 2022.In the version of this article initially published, members of the PASSPORT Study Group were listed in Supplementary information but not included in the main article. The contributors are listed below for inclusion in authorship.